Remove tag doctorly
article thumbnail

STAT+: Steward Health Care has deal to sell doctor network to UnitedHealth

STAT

A price tag was not included in documents filed with the state, and Optum officials did not immediately respond to comment. On Tuesday, a subsidiary of Optum, Collaborative Care Holdings, LLC, filed notice with the state’s Health Policy Commission over the sale. Continue to STAT+ to read the full story…

Hospitals 330
article thumbnail

Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies

STAT

But executives at four health systems using the software, called DAX, told STAT that while the software might make it possible to see more patients, or justify higher charges to insurers for visits, the high price tag means it’s certainly not boosting their bottom lines.

Hospitals 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novelist John Green launches attack on Cepheid over the price of its TB test

STAT

Halve the $10 price tag, Green maintained, and the company can save lives by giving more people access to early detection of TB. But in a scathing YouTube video posted Tuesday, Green argued the price is prohibitive for patients in lower-income countries. Citing an analysis from Doctors without Borders, he noted the tests cost around $4.64

342
342
article thumbnail

The Voice of Your Brand: Create Your Brand’s Sonic Soul A tribute to Sylvester daCunha

PharmaState Academy

That’s the power of sound in a tag line. As a pharma brand manager, I learned from Sylvester daCunha the importance of creating soulful taglines which can communicate the ‘Voice of Your Brand’. More so in today’s era when a doctor gives a medical representative just 3 seconds! He has just 3 seconds seconds. How will he stand out?

article thumbnail

Biogen’s Aduhelm rollout goes from bad to worse

pharmaphorum

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug. Analysts meanwhile have suggested that Aduhelm may start to pick up momentum if that review is positive.

118
118
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise.

Cerner 111
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. The Scottish Medicines Consortium is expected to publish its final advice on the drug later this year.

Hospitals 111